Klaudia Anna Tokarska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Klaudia Anna Tokarska has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia Tsopanidou
Division of Glial Disease and Therapeutics, Center for Translational Neuromedicine, University of Copenhagen, 2200 Copenhagen, Denmark
1 shared publication - Celia Kjaerby
Center for Translational Neuromedicine, University of Copenhagen
1 shared publication - Elise Schiøler Nielsen
Division of Glial Disease and Therapeutics, Center for Translational Neuromedicine, University of Copenhagen, 2200 Copenhagen, Denmark
1 shared publication - Eszter Rebeka Kovács
Division of Glial Disease and Therapeutics, Center for Translational Neuromedicine, University of Copenhagen, 2200 Copenhagen, Denmark
1 shared publication - Josephus L. M. van Rooij
Department of Neurology and Neurosurgery, UMC Utrecht Brain Center, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands
1 shared publication - Maiken Nedergaard
University of Copenhagen
1 shared publication
Latest Publications
- Open Access
Coordinated infraslow cortical oscillations of neuromodulators during NREM sleep
SUMMARY: Neurotransmitters and neuromodulators regulate brain states through diverse mechanisms, yet how their activities are coordinated during sleep remains unresolved. Using in vivo fiber photometry in adult mice expressing genetically encoded fluorescent biosensors, combined with EEG/EMG recordings, we investigated the temporal organization of multiple neuromodulators during sleep in barrel cortex, with norepinephrine (NE) as a reference signal. All five neuromodulators examined, acetylcholine, serotonin, dopamine, histamine, and NE, exhibited synchronized infraslow cortical oscillations during NREM sleep. Optogenetic suppression of locus coeruleus (LC) neurons abolished NE oscillations and selectively reduced acetylcholine fluctuations in barrel cortex, whereas targeted inhibition of basal forebrain cholinergic neurons attenuated REM-associated acetylcholine elevations without disrupting NREM-related oscillations or NE dynamics. The synchronized infraslow cortical oscillations spanning multiple neuromodulators reveal a previously unrecognized mechanism for organizing sleep architecture.
Open AccessCoordinated infraslow cortical oscillations of neuromodulators during NREM sleep
SUMMARY: Neurotransmitters and neuromodulators regulate brain states through diverse mechanisms, yet how their activities are coordinated during sleep remains unresolved. Using in vivo fiber photometry in adult mice expressing genetically encoded fluorescent biosensors, combined with EEG/EMG recordings, we investigated the temporal organization of multiple neuromodulators during sleep in barrel cortex, with norepinephrine (NE) as a reference signal. All five neuromodulators examined, acetylcholine, serotonin, dopamine, histamine, and NE, exhibited synchronized infraslow cortical oscillations during NREM sleep. Optogenetic suppression of locus coeruleus (LC) neurons abolished NE oscillations and selectively reduced acetylcholine fluctuations in barrel cortex, whereas targeted inhibition of basal forebrain cholinergic neurons attenuated REM-associated acetylcholine elevations without disrupting NREM-related oscillations or NE dynamics. The synchronized infraslow cortical oscillations spanning multiple neuromodulators reveal a previously unrecognized mechanism for organizing sleep architecture.
- Open Access
Central Nervous System Progression in Primary Vitreoretinal Lymphoma with Bilateral and Unilateral Involvement: A Systematic Review and Meta-Analysis
Background: Primary vitreoretinal lymphoma (PVRL) is either unilateral or bilateral at initial presentation. Progression to a central nervous system (CNS) lymphoma is regularly observed and these patients seem to have an inferior survival. Knowledge of the predictive value of laterality for CNS progression may facilitate risk stratification and the development of more effective treatment strategies, and eventually, improve outcomes. The objective of this analysis is to estimate the risk of CNS progression for patients with bilateral versus unilateral involvement of PVRL. Methods: Systematic literature search for studies on CNS progression in PVRL with bilateral and unilateral involvement according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We assessed the risk of bias and the methodological quality of studies using the Quality in Prognosis Studies (QUIPS) tool. Risk ratios of CNS progression in PVRL with bilateral and unilateral involvement were calculated and combined via a meta-analysis. Results: Twenty-five small-sized (total n = 371 cases) studies were included. The majority of the studies were at medium to high risk of bias. Results suggest no significant difference in CNS progression between bilateral and unilateral PVRL, with a pooled relative risk ratio of 1.12 (95% confidence interval 0.89–1.41). Conclusions: CNS progression is common in PVRL. From the limited available evidence, there is no significant difference in CNS progression between bilateral and unilateral PVRL.
Open AccessCentral Nervous System Progression in Primary Vitreoretinal Lymphoma with Bilateral and Unilateral Involvement: A Systematic Review and Meta-Analysis
Background: Primary vitreoretinal lymphoma (PVRL) is either unilateral or bilateral at initial presentation. Progression to a central nervous system (CNS) lymphoma is regularly observed and these patients seem to have an inferior survival. Knowledge of the predictive value of laterality for CNS progression may facilitate risk stratification and the development of more effective treatment strategies, and eventually, improve outcomes. The objective of this analysis is to estimate the risk of CNS progression for patients with bilateral versus unilateral involvement of PVRL. Methods: Systematic literature search for studies on CNS progression in PVRL with bilateral and unilateral involvement according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We assessed the risk of bias and the methodological quality of studies using the Quality in Prognosis Studies (QUIPS) tool. Risk ratios of CNS progression in PVRL with bilateral and unilateral involvement were calculated and combined via a meta-analysis. Results: Twenty-five small-sized (total n = 371 cases) studies were included. The majority of the studies were at medium to high risk of bias. Results suggest no significant difference in CNS progression between bilateral and unilateral PVRL, with a pooled relative risk ratio of 1.12 (95% confidence interval 0.89–1.41). Conclusions: CNS progression is common in PVRL. From the limited available evidence, there is no significant difference in CNS progression between bilateral and unilateral PVRL.